Search Results - "Sfontouris, I"

Good practice recommendations on add-ons in reproductive medicine by Lundin, K, Bentzen, J G, Bozdag, G, Ebner, T, Harper, J, Le Clef, N, Moffett, A, Norcross, S, Polyzos, N P, Rautakallio-Hokkanen, S, Sfontouris, I, Sermon, K, Vermeulen, N, Pinborg, A

“…Abstract STUDY QUESTION Which add-ons are safe and effective to be used in ART treatment? SUMMARY ANSWER Forty-two recommendations were formulated on the use…”
Get full text

Interleukin 15 concentrations in follicular fluid and their effect on oocyte maturation in subfertile women undergoing intracytoplasmic sperm injection by Spanou, S., Kalogiannis, D., Zapanti, E., Gazouli, M., Sfontouris, I. A., Siristatidis, C., Mastorakos, George

“…Purpose To calculate the concentrations of interleukin 15 (IL-15) in follicular fluid (FF) and evaluate their relation with oocyte maturation, follicle size,…”
Get full text

Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome? by Lainas, G T, Lainas, T G, Sfontouris, I A, Chatzimeletiou, K, Venetis, C A, Bosdou, J K, Tarlatzis, B C, Grimbizis, G F, Kolibianakis, E M

“…Are oocyte maturation rates different among 0.1, 0.2 and 0.4 mg triptorelin used for triggering final oocyte maturation in patients at high risk for ovarian…”
Get full text

OC05: Ultrasound and hematological early-luteal-phase predictors of severe ovarian hyperstimulation syndrome in high-risk patients following triggering of final oocyte maturation with human chorionic gonadotropin by Sfontouris, I, Lainas, G, Lainas, T, Venetis, C, Makris, A, Tarlatzis, B, Kolibianakis, E

Get full text

OC05 by Sfontouris, I., Lainas, G., Lainas, T., Venetis, C., Makris, A., Tarlatzis, B., Kolibianakis, E.

Get full text

Serum vascular endothelial growth factor levels following luteal gonadotrophin‐releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome by Lainas, GT, Kolibianakis, EM, Sfontouris, IA, Zorzovilis, IZ, Petsas, GK, Lainas, TG, Tarlatzis, BC

“…Objective To investigate the kinetics of serum vascular endothelial growth factor (VEGF) following gonadotrophin‐releasing hormone (GnRH) antagonist…”
Get full text

No evidence that embryo selection by near-infrared spectroscopy in addition to morphology is able to improve live birth rates: results from an individual patient data meta-analysis by Vergouw, C.G., Heymans, M.W., Hardarson, T., Sfontouris, I.A., Economou, K.A., Ahlström, A., Rogberg, L., Lainas, T.G., Sakkas, D., Kieslinger, D.C., Kostelijk, E.H., Hompes, P.G.A., Schats, R., Lambalk, C.B.

“…STUDY QUESTION What is the value of embryo selection by metabolomic profiling of culture medium with near-infrared (NIR) spectroscopy as an adjunct to…”
Get full text

Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome by Lainas, G. T., Lainas, T. G., Venetis, C. A., Sfontouris, I. A., Zorzovilis, I. Z., Alexopoulou, E., Tarlatzis, B. C., Kolibianakis, E. M.

“…ABSTRACT Objective To assess ultrasound and hematological changes during the early luteal phase following triggering of final oocyte maturation with human…”
Get full text

Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS by Lainas, G.T., Kolibianakis, E.M., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, T.G., Tarlatzis, B.C.

“…STUDY QUESTION Do high-risk patients who develop severe early ovarian hyperstimulation syndrome (OHSS) and receive low-dose GnRH antagonist in the luteal phase…”
Get full text

A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCG by Lainas, GT, Lainas, TG, Sfontouris, IA, Venetis, CA, Kyprianou, MA, Petsas, GK, Tarlatzis, BC, Kolibianakis, EM

“…Abstract STUDY QUESTION Can the grade of ascites, haematocrit (Ht), white blood cell (WBC) count and maximal ovarian diameter (MOD) measured on Day 3 be used…”
Get full text

Triggering final oocyte maturation with gnrh agonist in patients with polycystic ovaries undergoing IVF by Kolibianakis, E.M, Kyrou, D, Venetis, C.A, Sfontouris, I, Lainas, T.G, Tarlatzis, B.C

Get full text

Triggering of final oocyte maturation with gonadotrophin releasing hormone agonist in patients with polycystic ovaries undergoing in vitro fertilization by Tarlatzi, T.B, Kolibianakis, E.M, Bosdou, J.K, Venetis, C.A, Makedos, A, Chatzimeletiou, K, Zepiridis, L, Lainas, G, Sfontouris, I, Lainas, T, Tarlatzis, B.C

Get full text

Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist by Lainas, TG, Sfontouris, IA, Zorzovilis, IZ, Petsas, GK, Lainas, GT, Kolibianakis, EM

“…Abstract Several approaches have been proposed for the management of OHSS that reduce, but do not completely eliminate the incidence of human chorionic…”
Get full text

Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol by Lainas, TG, Sfontouris, IA, Zorzovilis, IZ, Petsas, GK, Lainas, GT, Iliadis, GS, Kolibianakis, EM

“…Abstract Despite the fact that many methods have been proposed for the management of severe ovarian hyperstimulation syndrome (OHSS), its prevention is mainly…”
Get full text

Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase by Lainas, TG, Sfontouris, IA, Zorzovilis, IZ, Petsas, GK, Lainas, GT, Alexopoulou, E, Kolibianakis, EM

“…Abstract Ovarian hyperstimulation syndrome (OHSS) is a serious complication of ovarian stimulation protocols. Currently, no curative therapy exists and the…”
Get full text

A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases by Tzioufas, Athanasios G., Bakasis, Athanasios-Dimitrios, Goules, Andreas V., Bitzogli, Kleopatra, Cinoku, Ilir I., Chatzis, Loukas G., Argyropoulou, Ourania D., Venetsanopoulou, Aliki I., Mavrommati, Maria, Stergiou, Ioanna E., Pezoulas, Vasilis, Voulgari, Paraskevi V., Katsimpari, Chaido, Katechis, Spyridon, Gazi, Souzana, Katsifis, Gkikas, Sfontouris, Charalampos I., Georgountzos, Athanasios I., Liossis, Stamatis-Nick, Papagoras, Charalampos, Fotiadis, Dimitrios I., Skopouli, Fotini N., Vlachoyiannopoulos, Panayiotis G., Moutsopoulos, Haralampos M.

“…To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients…”
Get full text

P-280 Potential for improvement and current limitations of Artificial Intelligence (AI) for embryo selection: analysis of external validation data by Sfontouris, I, Nikiforaki, D, Liarmakopoulou, S, Sialakouma, A, Koutsi, A, Polia, A, Belmpa, M, Theodoratos, S, Walker, J, Makrakis, E

“…Abstract Study question What are the prospects of improvement and the limitations of an AI system for embryo selection? Summary answer The predictive…”
Get full text

O-239 A model based on artificial intelligence for the non-invasive prediction of embryo aneuploidy by Polia, A, Anagnostara, K, Belmpa, M, Giannelou, P, Karagianni, T, Mastromina, I, Nikiforaki, D, Sialakouma, A, Tsorva, E, Davies, S, Sfontouris, I

“…Abstract Study question Can the automated artificial intelligence (AI) model iDAScore predict embryo aneuploidy? Summary answer The AUC for aneuploidy…”
Get full text

O-240 Embryo assessment: the Istanbul consensus revised by Coticchio, G, Ahlström, A, Arroyo, G, Balaban, B, Campbell, A, De Los Santos Molina, M  J, Ebner, T, Gardner, D, Kovacic, B, Lundin, K, Magli, C, Mcheik, S, Morbeck, D, Rienzi, L, Sfontouris, I, Vermeulen, N, Alikani, M

“…Abstract Study question What are the current recommended criteria for morphological assessment of oocytes, zygotes and embryos? Summary answer The present…”
Get full text

Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles by Venetis, Christos A., Kolibianakis, Efstratios M., Bosdou, Julia K., Lainas, George T., Sfontouris, Ioannis A., Tarlatzis, Basil C., Lainas, Tryfon G.

“…STUDY QUESTION What is the proper way of assessing the effect of progesterone elevation (PE) on the day of hCG on live birth in women undergoing fresh embryo…”
Get full text